159 related articles for article (PubMed ID: 12044480)
1. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
Marti M; Guerrini R; Beani L; Bianchi C; Morari M
Neuroscience; 2002; 112(1):153-60. PubMed ID: 12044480
[TBL] [Abstract][Full Text] [Related]
2. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
[TBL] [Abstract][Full Text] [Related]
3. Endogenous nociceptin/orphanin FQ (N/OFQ) contributes to haloperidol-induced changes of nigral amino acid transmission and parkinsonism: a combined microdialysis and behavioral study in naïve and nociceptin/orphanin FQ receptor knockout mice.
Mabrouk OS; Marti M; Morari M
Neuroscience; 2010 Mar; 166(1):40-8. PubMed ID: 20006677
[TBL] [Abstract][Full Text] [Related]
4. The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway.
Marti M; Trapella C; Viaro R; Morari M
J Neurosci; 2007 Feb; 27(6):1297-307. PubMed ID: 17287504
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
[TBL] [Abstract][Full Text] [Related]
6. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis.
Murphy NP; Maidment NT
J Neurochem; 1999 Jul; 73(1):179-86. PubMed ID: 10386969
[TBL] [Abstract][Full Text] [Related]
7. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
8. Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.
Ferraro L; Tomasini MC; Fernandez M; Bebe BW; O'Connor WT; Fuxe K; Glennon JC; Tanganelli S; Antonelli T
Neuroscience; 2001; 102(1):113-20. PubMed ID: 11226674
[TBL] [Abstract][Full Text] [Related]
9. Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release.
Marti M; Mela F; Guerrini R; Calò G; Bianchi C; Morari M
J Neurochem; 2004 Dec; 91(6):1501-4. PubMed ID: 15584926
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.
Morari M; Sbrenna S; Marti M; O'Connor WT; Bianchi C; Fuxe K; Beani L
Eur J Neurosci; 1998 May; 10(5):1716-22. PubMed ID: 9751143
[TBL] [Abstract][Full Text] [Related]
11. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
12. Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity.
Volta M; Viaro R; Trapella C; Marti M; Morari M
Exp Neurol; 2011 Mar; 228(1):126-37. PubMed ID: 21215744
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin/orphanin FQ modulates motor behavior and primary motor cortex output through receptors located in substantia nigra reticulata.
Marti M; Viaro R; Guerrini R; Franchi G; Morari M
Neuropsychopharmacology; 2009 Jan; 34(2):341-55. PubMed ID: 18418358
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats.
Albrecht D; Blühdorn R; Siegmund H; Berger H; Calo' G
Br J Pharmacol; 2001 Sep; 134(2):333-42. PubMed ID: 11564651
[TBL] [Abstract][Full Text] [Related]
15. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
16. Panicolytic-like effects caused by substantia nigra pars reticulata pretreatment with low doses of endomorphin-1 and high doses of CTOP or the NOP receptors antagonist JTC-801 in male Rattus norvegicus.
da Silva JA; Biagioni AF; Almada RC; de Freitas RL; Coimbra NC
Psychopharmacology (Berl); 2017 Oct; 234(20):3009-3025. PubMed ID: 28856406
[TBL] [Abstract][Full Text] [Related]
17. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
[TBL] [Abstract][Full Text] [Related]
18. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
Eur J Pharmacol; 1999 Dec; 385(2-3):R3-5. PubMed ID: 10607891
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
Marti M; Mela F; Bianchi C; Beani L; Morari M
J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
